While many use marijuana for managing chronic pain or as a way to unwind at the end of the day, according to UW Medicine, ...

The U.S. FDA has approved narsoplimab (Yartemlea) as the first indicated therapy for hematopoietic stem cell ...

Health-related social needs in HF, removing age from frailty scores, CIED concerns about smartwatches, and more.

Omeros to Host Conference Call Monday, December 29, 2025 at 4:30 p.m. ET -- -- First and only approved option: YARTEMLEA(R) is the only approved treatment for hematopoietic stem cell ...

Omeros Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved YARTEMLEA® (narsoplimab-wuug) for the treatment of hematopoietic stem cell transplant-associated ...

Omeros (OMER) receives FDA approval for Yartemlea (narsoplimab) in TA-TMA, driving shares up nearly 80% to a $1bn+ valuation.

Long-term exposure to certain components of fine particulate air pollution was associated with a higher risk of developing depression among older adults.

This is the latest study to suggest that GLP-1s, particularly semaglutide, are tied to a reduced risk for epilepsy in type 2 diabetes.

Seborrheic dermatitis is associated with other epithelial barrier diseases of the skin and beyond, including the respiratory, ...

Background Multiple long-term conditions (MLTCs) are common among individuals with heart failure (HF); however, the influence ...

Inherited retinal degenerations (IRDs) were found by Mass Eye and Ear researchers to occur in only 28% of people who carry IRD genetic ...

This study found that certain characteristics in linked electronic health record data across episodes of care can help identify patients with Alzheimer disease and related dementias at high risk of 30 ...